- Home
- VCIG vs ANVS Comparison
VCIG vs ANVS Comparison
Compare VCIG & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCIG
- ANVS
- Stock Information
- Founded
- VCIG 2013
- ANVS 2008
- Country
- VCIG Malaysia
- ANVS United States
- Employees
- VCIG N/A
- ANVS N/A
- Industry
- VCIG Diversified Commercial Services
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- VCIG Consumer Discretionary
- ANVS Health Care
- Exchange
- VCIG Nasdaq
- ANVS Nasdaq
- Market Cap
- VCIG 26.3M
- ANVS 31.2M
- IPO Year
- VCIG 2023
- ANVS 2020
- Fundamental
- Price
- VCIG $0.33
- ANVS $1.48
- Analyst Decision
- VCIG
- ANVS Strong Buy
- Analyst Count
- VCIG 0
- ANVS 5
- Target Price
- VCIG N/A
- ANVS $37.00
- AVG Volume (30 Days)
- VCIG 2.6M
- ANVS 257.8K
- Earning Date
- VCIG 04-08-2025
- ANVS 05-12-2025
- Dividend Yield
- VCIG 149.39%
- ANVS N/A
- EPS Growth
- VCIG N/A
- ANVS N/A
- EPS
- VCIG 7.82
- ANVS N/A
- Revenue
- VCIG $23,548,256.00
- ANVS N/A
- Revenue This Year
- VCIG N/A
- ANVS N/A
- Revenue Next Year
- VCIG N/A
- ANVS N/A
- P/E Ratio
- VCIG $0.05
- ANVS N/A
- Revenue Growth
- VCIG 89.38
- ANVS N/A
- 52 Week Low
- VCIG $0.29
- ANVS $1.43
- 52 Week High
- VCIG $68.60
- ANVS $20.00
- Technical
- Relative Strength Index (RSI)
- VCIG 27.31
- ANVS 30.83
- Support Level
- VCIG $0.70
- ANVS $1.43
- Resistance Level
- VCIG $0.91
- ANVS $2.07
- Average True Range (ATR)
- VCIG 0.12
- ANVS 0.14
- MACD
- VCIG -0.02
- ANVS 0.04
- Stochastic Oscillator
- VCIG 6.10
- ANVS 7.03
About VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development solution consultancy. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology Consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment which focuses on listing solutions, investor relations, and boardroom strategies consultancy. It has established a diverse local and international clientele, providing them with its services in both local and cross-border listings. Its role begins with pre-listing diagnosis and planning to the finalization of the entire listing process.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.